Sectra awarded Best in KLAS for customer service for 11th consecutive year

Swedish medical imaging company Sectra has been awarded multiple Best in KLAS awards for the 11th year in a row, taking home the No. 1 rank for customer satisfaction in the U.S. and Canada. KLAS Research also recognized Sectra in new categories for Northern and Southern Europe.

The company took home Best in KLAS honors for its PACS and enterprise imaging platforms, which are used across the globe by private, academic and government healthcare institutions. 

"These awards showcase our excellent employees who continuously go above and beyond to meet customer needs,” Marie Ekström Trägårdh, executive vice president of Sectra AB and president of Sectra Imaging IT Solutions said in a statement. “Over the past year, we have restructured our organization into teams to ensure consistent and knowledgeable guidance throughout the sales, implementation, and support phases of the customer journey. This, along with product offerings that reduce IT costs, increase security, and grow with our users' enterprise imaging requirements, has solidified our success.”

Launching its first PACS system in Sweden in 1993, Sectra now boasts more than 2,500 sites worldwide. In December, Sectra was awarded a 10-year contract with the National Health Services in Scotland to manage and secure medical images in 14 territories. The company also made news last year for its partnership with Vanderbilt Health, where Sectra’s technology supports patient care and ongoing research. 

The full list of 2024 Best in KLAS awards can be found by clicking here.

Chad Van Alstin Health Imaging Health Exec

Chad is an award-winning writer and editor with over 15 years of experience working in media. He has a decade-long professional background in healthcare, working as a writer and in public relations.

Around the web

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.